Meiji Yasuda Life Insurance’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $574K | Hold |
10,451
| – | – | 0.02% | 178 |
|
|
2025
Q1 | $739K | Sell |
10,451
-491
| -4% | -$34.7K | 0.01% | 169 |
|
|
2024
Q4 | $719K | Hold |
10,942
| – | – | 0.01% | 173 |
|
|
2024
Q3 | $769K | Hold |
10,942
| – | – | 0.01% | 166 |
|
|
2024
Q2 | $901K | Buy |
10,942
+4,000
| +58% | +$329K | 0.02% | 168 |
|
|
2024
Q1 | $606K | Sell |
6,942
-1,934
| -22% | -$169K | 0.01% | 204 |
|
|
2023
Q4 | $856K | Sell |
8,876
-980
| -10% | -$94.5K | 0.02% | 180 |
|
|
2023
Q3 | $872K | Sell |
9,856
-339
| -3% | -$30K | 0.02% | 166 |
|
|
2023
Q2 | $884K | Buy |
10,195
+670
| +7% | +$58.1K | 0.02% | 173 |
|
|
2023
Q1 | $926K | Buy |
9,525
+1,278
| +15% | +$124K | 0.02% | 166 |
|
|
2022
Q4 | $853K | Buy |
8,247
+450
| +6% | +$46.5K | 0.02% | 165 |
|
|
2022
Q3 | $661K | Buy |
7,797
+3,857
| +98% | +$327K | 0.01% | 190 |
|
|
2022
Q2 | $327K | Buy |
+3,940
| New | +$327K | 0.01% | 237 |
|